Cargando…
Current Trends in Circulating Biomarkers for Melanoma Detection
Melanomas have increased in global incidence and are the leading cause of skin cancer deaths. Whilst the majority of early-stage, non-metastatic melanomas can be cured with surgical excision alone, ~5% of patients with early melanomas will experience recurrence following a variable disease-free inte...
Autores principales: | Huang, Nancy, Lee, Katie J., Stark, Mitchell S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038522/ https://www.ncbi.nlm.nih.gov/pubmed/35492361 http://dx.doi.org/10.3389/fmed.2022.873728 |
Ejemplares similares
-
On Naevi and Melanomas: Two Sides of the Same Coin?
por: Lee, Katie J., et al.
Publicado: (2021) -
The Future of Precision Prevention for Advanced Melanoma
por: Lee, Katie J., et al.
Publicado: (2022) -
Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects
por: Deacon, Dekker C., et al.
Publicado: (2021) -
Current Understanding of Circulating Biomarkers in Pulmonary Hypertension Due to Left Heart Disease
por: Todd, Noah, et al.
Publicado: (2020) -
A group of three miRNAs can act as candidate circulating biomarkers in liquid biopsies from melanoma patients
por: De Martino, Eleonora, et al.
Publicado: (2023)